These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 26610475)

  • 1. Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases.
    He F; Zuo L
    Int J Mol Sci; 2015 Nov; 16(11):27770-80. PubMed ID: 26610475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach?
    De Rosa S; Cirillo P; Paglia A; Sasso L; Di Palma V; Chiariello M
    Curr Vasc Pharmacol; 2010 Mar; 8(2):259-75. PubMed ID: 19758111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ; Watumull DG; Campbell CL
    Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases.
    Taleb A; Ahmad KA; Ihsan AU; Qu J; Lin N; Hezam K; Koju N; Hui L; Qilong D
    Biomed Pharmacother; 2018 Jun; 102():689-698. PubMed ID: 29604588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.
    Victor VM; Rocha M
    Curr Pharm Des; 2007; 13(8):845-63. PubMed ID: 17430185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, endothelial dysfunction and atherosclerosis.
    Victor VM; Rocha M; Solá E; Bañuls C; Garcia-Malpartida K; Hernández-Mijares A
    Curr Pharm Des; 2009; 15(26):2988-3002. PubMed ID: 19754375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in reactive oxygen species and cardiovascular reperfusion physiology.
    Becker LB
    Cardiovasc Res; 2004 Feb; 61(3):461-70. PubMed ID: 14962477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress in Atherosclerosis.
    Kattoor AJ; Pothineni NVK; Palagiri D; Mehta JL
    Curr Atheroscler Rep; 2017 Sep; 19(11):42. PubMed ID: 28921056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the interaction among dietary antioxidants and reactive oxygen species.
    Seifried HE; Anderson DE; Fisher EI; Milner JA
    J Nutr Biochem; 2007 Sep; 18(9):567-79. PubMed ID: 17360173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology.
    Manea A
    Cell Tissue Res; 2010 Dec; 342(3):325-39. PubMed ID: 21052718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease.
    Yoshizumi M; Tsuchiya K; Tamaki T
    J Med Invest; 2001 Feb; 48(1-2):11-24. PubMed ID: 11286012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: mechanism for mediating pathology.
    Hool LC
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):229-34. PubMed ID: 18197892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.
    Kornfeld OS; Hwang S; Disatnik MH; Chen CH; Qvit N; Mochly-Rosen D
    Circ Res; 2015 May; 116(11):1783-99. PubMed ID: 25999419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion Injury.
    Zhou T; Chuang CC; Zuo L
    Biomed Res Int; 2015; 2015():864946. PubMed ID: 26509170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.